A3P Biomedical provides prostate cancer diagnosis and treatment. They specialize in advanced prostate cancer diagnostics. Their main product, Stockholm3, is a clinically and commercially validated blood test for the early detection of aggressive prostate cancer. The test combines protein markers, genetic markers, and clinical data in a proprietaryalgorithm for the purpose of detecting aggressive prostate cancer at an early stage.

Biotechnology

Health Care

Health Diagnostics

Life Sciences

A3P Biomedical

A3P Biomedical's headquarters in Stockholm, Sweden

Description

People (2)

Jobs (0)

Other offices